A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN
Clinical trial NCT05612633 · WITHDRAWN
Trial details
- NCT number
- NCT05612633
- Sponsor
- Samus Therapeutics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2023-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.